Millenson, Michael M.
Brigham and Women's Hospital · Beth Israel Deaconess Medical Center · Mayo Clinic · Memorial Sloan Kettering Cancer Center · Oregon Health & Science University · Dana-Farber Cancer Institute · Weill Cornell Medicine
2 papers on CoChat
Most cited papers
- Verified
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., et al. (2016) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersLymphoma Diagnosis and Treatment
Cited by 1,001
- Verified
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
Leonard, J. P., LaCasce, A. S., Smith, M. R., Noy, A., Chirieac, L. R., Rodig, S. J., Yu, J. Q., Vallabhajosula, S., Schoder, H., English, P., et al. (2012) · Blood
Lymphoma Diagnosis and TreatmentAdvanced Breast Cancer Therapies
Cited by 299
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free